Core Insights - Visionary Holdings Inc. has officially launched its medical-grade stem cell anti-aging product line, targeting the Chinese mainland and broader Asian markets [1][2] - This launch follows the company's entry into the stem cell and medical aesthetics sector and a strategic partnership with Jiangsu Yike Regenerative Medicine Co., Ltd. [2][3] Product Lines and Value Model - The anti-aging product portfolio includes three major categories: Life Rejuvenation Program, Precision Repair Package, and Premium Personalized Program [6] - The Life Rejuvenation Program combines mesenchymal stem cells, NK cell therapy, and AI-based diagnostics, aimed at high-net-worth individuals [6] - The Precision Repair Package integrates targeted stem cell therapy and blood purification for clients with specific conditions [6] - The Premium Personalized Program offers full-genome sequencing and customized health management for ultra-high-net-worth clients [6] Commercialization Strategy - The new products will be operated through the Asia-Pacific headquarters in Hong Kong, initially launching in Hong Kong, Singapore, and the Chinese mainland [4] - The company plans to establish a joint venture for localized manufacturing and validation of stem cell products [7] - A cross-border sales and distribution network will be built, covering mainland China, Hong Kong, Southeast Asia, and expanding into Canada, the United States, and Mexico [7] Management Perspective - The CEO of Visionary Holdings emphasized that the launch marks a significant milestone in converting technological assets into commercial value [4] - The company anticipates that this product line will drive profitability in upcoming fiscal years and enhance its visibility in global capital markets [5]